KODEX SYNTH-US BIOKODEX SYNTH-US BIOKODEX SYNTH-US BIO

KODEX SYNTH-US BIO

No trades
See on Supercharts

Key stats


Assets under management (AUM)
‪16.68 B‬KRW
Fund flows (1Y)
‪1.28 B‬KRW
Dividend yield (indicated)
Discount/Premium to NAV
−1.0%
Shares outstanding
‪608.00 K‬
Expense ratio
0.25%

About KODEX SYNTH-US BIO


Issuer
Samsung Life Insurance Co., Ltd.
Brand
KODEX
Home page
Inception date
Oct 31, 2013
Index tracked
S&P Biotechnology Select Industry
Replication method
Synthetic
Management style
Passive
ISIN
KR7185680006
KODEX Synth-US bio mainly focuses on USA's biotechnology companies committed to healthier future.

Classification


Asset Class
Equity
Category
Sector
Focus
Health care
Niche
Biotechnology
Strategy
Equal
Geography
U.S.
Weighting scheme
Equal
Selection criteria
Market cap

Returns


1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund


As of January 16, 2025
Exposure type
Bonds, Cash & Other
Cash
Miscellaneous
Bonds, Cash & Other100.00%
Cash50.25%
Miscellaneous43.49%
ETF6.27%
Stock breakdown by region
100%
North America100.00%
Latin America0.00%
Europe0.00%
Asia0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends


Dividend payout history

Assets under management (AUM)



Fund Flows